Grant: Catalyst Grant: Global Governance AMR & Related Infectious Disease Threats
University of Ottawa
$100,000.00
Mapping Canadian Knowledge of, and Involvement in, the Global Governance of Anti-Microbial Resistance and Related Infectious Diseases
EF 2017-18
Résumé
Antimicrobial resistance (AMR) is when an antibiotic can no longer kill bacteria, because they are resistant to it. AMR and related infectious diseases are widely considered to be among the world's next big global health challenges. An estimated 700,000 people die each year because of AMR. It has also been identified as a major threat to the global economy due to lost productivity. Trans-border health security threats posed by AMR implies an urgent need for global solutions that incorporate effective cross-sectoral governance arrangements and which mobilize a wide variety of state and non-state actors alike.
The objectives of this study are:
1) to advance Canadian research expertise through the identification of research gaps in global governance arrangements, structures, and institutions addressing AMR and related infectious disease threats; and
2) to develop an interdisciplinary Canadian network of researchers, scholars and knowledge users in the global governance of AMR. To achieve these goals we pose the following research questions (RQs):
RQ1. What Canadian research expertise exists about the role of global governance arrangements, structures, and institutions in addressing AMR and related infectious disease threats?
RQ2.Who are key Canadian (state and non-state) stakeholders, and how do they engage in various AMR governance fora domestically and internationally?
RQ3.What knowledge gaps in the global governance of AMR and related infectious diseases that would be amenable to new research investigation?
Programme
Catalyst Grant: Global Governance AMR & Related Infectious Disease Threats
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
375804
Name
Labonté Ronald
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Catalyst Grant : Global Governance AMR & Related Infectious Disease Threats
Projecttitle
Mapping Canadian Knowledge of, and Involvement in, the Global Governance of Anti-Microbial Resistance and Related Infectious Diseases
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Global Governance AMR & Related Infectious Disease Threats
Keyworddelim
Antimicrobial Resistance; Antimicrobial Stewardship; Antimicrobial Surveillance; Antimicrobial Use; Canada; Global Governance; Infectious Diseases; Population Health; Public Health; Public Policy
Abstract
Antimicrobial resistance (AMR) is when an antibiotic can no longer kill bacteria, because they are resistant to it. AMR and related infectious diseases are widely considered to be among the world's next big global health challenges. An estimated 700,000 people die each year because of AMR. It has also been identified as a major threat to the global economy due to lost productivity. Trans-border health security threats posed by AMR implies an urgent need for global solutions that incorporate effective cross-sectoral governance arrangements and which mobilize a wide variety of state and non-state actors alike.
The objectives of this study are:
1) to advance Canadian research expertise through the identification of research gaps in global governance arrangements, structures, and institutions addressing AMR and related infectious disease threats; and
2) to develop an interdisciplinary Canadian network of researchers, scholars and knowledge users in the global governance of AMR. To achieve these goals we pose the following research questions (RQs):
RQ1. What Canadian research expertise exists about the role of global governance arrangements, structures, and institutions in addressing AMR and related infectious disease threats?
RQ2.Who are key Canadian (state and non-state) stakeholders, and how do they engage in various AMR governance fora domestically and internationally?
RQ3.What knowledge gaps in the global governance of AMR and related infectious diseases that would be amenable to new research investigation?
Competitiondate
201710
Approvedterm2
1 yr 0 mth
Pinamesdelim
Labonté, Ronald; Noad, Lindsay
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~